Medical School News and Research

RSS

NIH selects Women & Infants to participate in Pelvic Floor Disorders Network

Women & Infants Hospital of Rhode Island has been selected by the National Institutes of Health (NIH) to participate in the national Pelvic Floor Disorders Network (PFDN). Women & Infants is one of just eight medical centers from across the US, and the only one in the Northeast, to work collaboratively to develop and perform research studies related to women with pelvic floor disorders.

21 Oct 2011

Agilent announces winners of 2011 eMerging Insights grant program

Agilent Technologies Inc. today announced the winners of the 2011 eMerging Insights grant program: Dr. Michael J. MacCoss of the University of Washington and Dr. Peter J. Park of Harvard University. Each will be awarded $75,000 toward their ongoing research on open source data-integration tools.

21 Oct 2011

Study links leptin levels with symptoms of depression, anxiety

A new study has for the first time in humans linked levels of leptin, a hormone produced by fat cells, with symptoms of depression and anxiety independent of weight.

21 Oct 2011

Young docs not so keen on immunizations: Survey

A cross-sectional survey of 551 healthcare providers and noted that more recent graduates were less likely to think that vaccines were efficacious said Saad Omer, assistant professor of Emory University in Atlanta. They were also more likely to have doubts about the safety of some vaccines, Omer told reporters at the 49th annual meeting of the Infectious Diseases Society of America (IDSA).

20 Oct 2011

Starting HIV therapy within two weeks of TB treatment increases survival by 33%

Timing is everything when treating patients with both HIV and tuberculosis. Starting HIV therapy in such patients within two weeks of TB treatment, rather than two months as is the current practice, increases survival by 33 percent, according to a large-scale clinical trial in Cambodia led by researchers at Children's Hospital Boston and the Immune Disease Institute.

20 Oct 2011

Study explores how internet message boards help women after pregnancy loss

Nearly one in six pregnancies end in miscarriage or stillbirth, but parents' losses are frequently minimized or not acknowledged by friends, family or the community.

20 Oct 2011

Florida State receives eight-year LCME accreditation

The Florida State University College of Medicine has been granted a maximum eight-year accreditation by the sanctioning body of U.S. medical schools.

20 Oct 2011

Scientists discover complex cell mechanism that becomes an obstacle for radiation effectiveness

Researchers from Massachusetts General Hospital, Harvard Medical School and CIC bioGUNE discover a complex cell mechanism activated by a protein —HOXB9— that becomes an obstacle for radiation effectiveness.

20 Oct 2011

BUSM, COE receive NIH training grant to examine inflammatory disorders

The National Institutes of Health (NIH) has awarded Boston University School of Medicine (BUSM) and the College of Engineering (COE) a five year, $316,875 training grant to examine inflammatory disorders.

20 Oct 2011

Many Americans do not have access to a 'medical home'

Many Americans do not have access to a "medical home"-a physician practice that is able to manage ongoing care for patients and coordinate care among specialists and other health care facilities, according to a University of Michigan Health System-led study.

19 Oct 2011

Heart-failure related hospitalizations has declined substantially among Medicare patients

Between 1998 and 2008, heart-failure related hospitalizations declined substantially among Medicare patients, but at a lower rate for black men, according to a study in the October 19 issue of JAMA. Also, 1-year mortality rates declined slightly during this period, but remain high.

19 Oct 2011

HMS launches Initiative in Systems Pharmacology

Taking aim at the alarming slowdown in the development of new and lifesaving drugs, Harvard Medical School is launching an Initiative in Systems Pharmacology, a comprehensive strategy to transform drug discovery by convening biologists, chemists, pharmacologists, physicists, computer scientists and clinicians to explore together how drugs work in complex systems.

18 Oct 2011

New DNA-based prenatal blood test can identify pregnancy with Down syndrome

A new DNA-based prenatal blood test that can strikingly reduce the number of risky diagnostic procedures needed to identify a pregnancy with Down syndrome is ready to be introduced into clinical practice.

18 Oct 2011

Scientists discover high levels of Fusobacterium in colorectal cancers

Scientists at Dana-Farber Cancer Institute and the Broad Institute have found strikingly high levels of a bacterium in colorectal cancers, a sign that it might contribute to the disease and potentially be a key to diagnosing, preventing, and treating it.

18 Oct 2011

NSU's medical school to educate medical residents in rural and underserved communities

Nova Southeastern University's (NSU) medical school announced it recently received a 5-year, $1 million federal grant to educate medical residents to provide expert care for patients living in rural and underserved communities.

15 Oct 2011

Cancer activist joins CNN medical correspondent for colon cancer research benefit event

Legendary journalist, best-selling author and cancer activist Katie Couric joins CNN's Sanjay Gupta, M.D. Nov. 1 for the fifth annual A Conversation With a Living Legend® luncheon benefiting The University of Texas MD Anderson Cancer Center.

15 Oct 2011

Exercise stimulates two beneficial proteins in women before and during pregnancy

Although exercise is generally considered to be a good thing for people with high blood pressure, it has traditionally been considered too risky for women who are also pregnant. Some studies suggest that exercise has benefits such as decreasing the risk of women developing preeclampsia, a condition that raises blood pressure to dangerously high levels but how this might happen has remained unknown.

15 Oct 2011

FDA approves PLC's U.S. pivotal trial of RenalGuard to prevent Contrast-Induced Nephropathy

PLC Systems Inc., a company focused on innovative medical device technologies, announced today that it has received final approval from the U.S. Food and Drug Administration to commence its U.S. pivotal trial to study the efficacy of the Company's RenalGuard Therapy and RenalGuard System in the prevention of Contrast-Induced Nephropathy.

14 Oct 2011

Different molecular mechanisms in suprachiasmatic nucleus linked to jet lag differences

It's no secret that long-distance, west-to-east air travel - Seattle to Paris, for example - can raise havoc with a person's sleep and waking patterns, and that the effects are substantially less pronounced when traveling in the opposite direction.

14 Oct 2011

BCL11A protein might serve as potential target for sickle cell disease

Flipping a single molecular switch can reverse illness in a model of sickle cell disease, according to a study by researchers at Children's Hospital Boston and Dana-Farber Cancer Institute. When turned off, the switch, a protein called BCL11A, allows the body to manufacture red blood cells with an alternate form of hemoglobin unaffected by the mutation that causes the disease.

14 Oct 2011